Provided by Tiger Trade Technology Pte. Ltd.

Merck

122.23
-0.0300-0.02%
Volume:1.47M
Turnover:180.01M
Market Cap:303.38B
PE:16.79
High:123.18
Open:122.19
Low:121.50
Close:122.26
52wk High:123.33
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.94
T/O Rate:0.06%
Dividend:3.24
Dividend Rate:2.65%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:37.17%
ROA:13.76%
PB:5.85
PE(LYR):16.79

Loading ...

Merck to Create Separate Cancer Business as Keytruda Patent Loss Looms

Reuters
·
2 hours ago

Merck's Strategic Shift Signals New Growth Horizons

Benzinga_recent_news
·
1 hour ago

BUZZ-U.S. STOCKS ON THE MOVE-Merck, Alphabet, JPMorgan Chase

Reuters
·
1 hour ago

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Domino's, Novo Nordisk

Reuters
·
2 hours ago

US STOCKS-Wall St futures decline as tariff uncertainty curbs risk appetite

Reuters
·
3 hours ago

BRIEF-Merck Evolves Human Health Operating Structure To Support Portfolio Execution

Reuters
·
3 hours ago

BUZZ-Merck rises as drugmaker revamps human health business

Reuters
·
3 hours ago

Merck to Split Cancer Division in Response to Keytruda Patent Expiration

Deep News
·
3 hours ago

Merck names Jannie Oosthuizen and Brian Foard to lead new Human Health business units

Reuters
·
3 hours ago

Merck & Co Inc - Organizes Human Health Into Two Business Units

THOMSON REUTERS
·
3 hours ago

Merck - Jannie Oosthuizen Appointed Executive Vice President & President, Oncology and Msd International

THOMSON REUTERS
·
3 hours ago

Merck & Co Inc - Brian Foard Will Join as Executive Vice President and President, Specialty, Pharma & Infectious Diseases, Effective March 2

THOMSON REUTERS
·
3 hours ago

Merck to create separate cancer business to offset Keytruda patent loss, WSJ reports

Reuters
·
4 hours ago

Merck plans to split human-health business into two divisions, WSJ says

TIPRANKS
·
4 hours ago

Merck Shares Rise 1% Premarket After WSJ Reports Co Creates Separate Cancer Business

THOMSON REUTERS
·
4 hours ago

BRIEF-Merck Creates Separate Cancer Business As Sales Pressure Looms - WSJ

Reuters
·
4 hours ago

Merck Is Splitting Its Pharmaceuticals Unit to Bolster Product Launches Before Its Cancer Drug Keytruda Loses Patent Protection- WSJ

THOMSON REUTERS
·
4 hours ago

Moderna and Merck Advance mRNA Cancer Vaccine Trial in First-Line Lung Cancer: What Investors Should Watch

TIPRANKS
·
Feb 21

Merck Initiated at Overweight by Barclays

Dow Jones
·
Feb 20

Barclays Initiates Coverage on Merck With Overweight Rating

MT Newswires Live
·
Feb 20